Home Page
References OMIM Gene GeneReviews HGMD HGNC
GENATLAS PHENOTYPE
last update : 14-05-2020
Symbol G6PDD
Location Xq28
Name G6PD deficiency
Corresponding gene G6PD
Main clinical features
  • deficiency of G6PD, in various forms, is the basis of favism, primaquine sensitivity and some other drug-sensitive hemolytic anemias, anemia and jaundice in the newborn, and chronic nonspherocytic hemolytic anemia
  • high frequency in Africans, Mediterraneans and Asians, heterozygote advantage viz-a-viz malaria
  • 5 classes according to the level of enzyme activity
  • Class 1: Enzyme deficiency with chronic nonspherocytic hemolytic anemia Class 2: Severe enzyme deficiency (less than 10%) Class 3: Moderate to mild enzyme deficiency (10-60%) Class 4: Very mild or no enzyme deficiency (60%) Class 5: Increased enzyme activity
    Genetic determination sex linked
    Prevalence Glucose-6-phosphate deficiency is the most prevalent enzyme deficiency, with an estimated 400 million people affected worldwide
    Function/system disorder hematology
    Type disease
    Gene product
    Name glucose-6-phosphate dehydrogenase (G6PD)
    Remark(s) . women heterozygous for G6PD mutations exhibit variation in the loss of enzyme activity with preferential X-inactivation of the G6PD wild-type allele determined in heterozygotes (PMID: 24958328))
  • restoration of enzymatic activity in G6PD-deficient nucleated cells is feasible through modulation of G6PD transcription (PMID: 24805191))
  • Genotype/Phenotype correlations this inherited deficiency causes neonatal hyperbilirubinemia and chronic hemolytic anemia. Although most affected individuals are asymptomatic, exposure to oxidative stressors such as certain drugs or infection, can elicit acute hemolysis.